Our research activity focuses on the development of advanced molecular diagnostics technologies and point-of-care devices for early detection and management of diseases. Our highly multidisciplinary research activities combines the fundamental and translational studies at the interface between chemistry, physics, nanotechnology, and biology.
142
Publications
$7.5M
Total Funding
4900
Citation Count
474
Verified Review
Latest Research
Nanomachineries for Exosomes and Exosomal Biomarkers Analysis

The Shiddiky Laboratory is pursuing studies of the development of multifunctional magnetic nanomaterials based novel nanomachineries for the highly selective isolation and sensitive detection of exosome and exosomal biomarkers in patients with cancer and other diseases.

Read More About Nanomachineries

Nanomachineries for Exosomes and Exosomal Biomarkers Analysis
‘Metal-Biomolecules’ Affinity Interaction for Genetic, Epigenetic, and Proteomic Biomarkers

A novel platform method based on metal-biomolecules affinity interaction (i.e., adsorption) for the analysis of a range of genetic, epigenetic, and proteomic biomarkers in patients with cancers and other diseases. This method can overcome the major technological drawbacks in current biosensing approaches.

Read More About Nanobiosensing

‘Metal-Biomolecules’ Affinity Interaction for Genetic, Epigenetic, and Proteomic Biomarkers
Twitter Feed

#GriffithUni researchers are developing a low-cost tool for rapid detection of Cryptosporidium in drinking and recreational water as part of a new @arc_gov_au #LinkageProject http://ow.ly/6bGe50EaPCi

Celebrating our recent ARC grant success with few super smart students and colleagues - you guys are awesome ! I appreciate your hard work and dedication - Thanks to ARC for recognising our effort and hard work. @muhammad_umer @narshone @QmncGriffith @Griffith_Uni

Load More...